Welcome to our dedicated page for Crocs SEC filings (Ticker: CROX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Crocs, Inc. filings document the operations, governance and capital structure of a branded casual footwear company built around the Crocs and HEYDUDE brands. Form 8-K reports furnish earnings releases covering revenue, channel performance, gross margin, non-GAAP reconciliations, outlook commentary, cash flow, share repurchases and debt activity.
Proxy materials cover annual meeting matters, board and executive compensation disclosures, equity award information and pay-versus-performance data. Other material-event filings describe executive appointments and related compensatory arrangements, providing formal records of leadership and governance changes within the company.
FRASCH RONALD reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Ronald Frasch received an equity grant of common stock as part of his board compensation. He was awarded 1,252 shares of common stock on June 9, 2026 at a stated price of $0.00 per share, reflecting a non-cash compensation award.
According to the filing, this represents the annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan. Following this grant, Frasch directly holds a total of 76,180 shares of Crocs common stock.
Bickley Ian reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. disclosed that director Ian Bickley received an equity award of common stock. On June 9, 2026, he was granted 1,252 shares of Common Stock at a price of $0.00 per share as an annual grant for non-employee directors.
Following this award, Bickley directly holds 31,609 shares of Crocs common stock. The footnote explains that this represents the annual common stock grant made under the company’s Board of Directors Compensation Plan, reflecting routine, compensation-related equity rather than an open-market purchase.
HUGHES CHARISSE FORD reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Charisse Ford Hughes received an equity award of 1,252 shares of common stock equivalent as compensation. The award is structured as restricted stock units granted at no cash cost per unit. After this grant, her direct holdings total 16,703 shares of Crocs common stock.
The RSUs vest upon the earlier of her separation from the Board of Directors or a change in control of Crocs. Each restricted stock unit represents the right to receive one share of common stock in the future, reflecting standard non-employee director compensation under the company’s Board of Directors Compensation Plan.
KAPLAN BETH J reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Beth J. Kaplan received an equity award of 1,252 shares of common stock as part of her annual compensation. The shares were granted at no cash cost to her and bring her directly held stake to 14,374 shares. The footnote explains this is the regular annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan, indicating a routine, compensation-related transaction rather than an open-market trade.
REPLOGLE JOHN B reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director John B. Replogle received a stock-based compensation award of 1,252 shares of common stock on June 9, 2026. The shares were granted at no cash cost as the annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan, and increased his direct holdings to 19,669 shares.
Crocs, Inc. director Neeraj Tolmare reported stock-based compensation awards rather than open-market trades. On 2026-06-09, he acquired 1,095 shares of common stock and 1,252 additional shares at a stated price of $0.00 per share.
The 1,095-share grant represents the annual common stock grant to non-employee directors under the Board of Directors Compensation Plan. The 1,252-share award reflects his election to receive restricted stock in lieu of the cash retainer for Board and committee service, with these restricted shares vesting in four equal quarterly installments from the issuance date.
Crocs, Inc. director Douglas J. Treff reported stock-based compensation awards rather than market trades. On June 9, 2026, he acquired 1,291 shares of Common Stock as part of the annual grant to non-employee directors and 1,252 shares of restricted stock elected in lieu of cash retainers under the Board of Directors Compensation Plan. These awards were granted at $0.00 per share as compensation, not open-market purchases, and left him holding tens of thousands of shares directly.
SMACH THOMAS J reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Thomas J. Smach received equity compensation in the form of common stock. He was granted 1,291 shares directly and 2,817 shares to a trust under the Board of Directors Compensation Plan, electing restricted stock instead of cash retainers. After these awards, he holds 90,249 shares directly and 111,063 shares indirectly via a trust, plus additional indirect holdings through his spouse and a child, with beneficial ownership of the child’s shares disclaimed except for any pecuniary interest.
Crocs, Inc. held its 2026 annual stockholder meeting as a virtual audio webcast on June 9, 2026. Stockholders approved the new 2026 Equity Incentive Plan, which allows a range of stock- and cash-based awards and replaces the 2020 Equity Incentive Plan effective upon this vote.
Class III directors Thomas J. Smach, Beth J. Kaplan, and Neeraj S. Tolmare were elected to serve until the 2029 annual meeting or until their successors are qualified. Stockholders also ratified Deloitte & Touche LLP as independent auditor for fiscal 2026 and approved, on an advisory basis, the compensation of named executive officers.
Crocs, Inc. Chief Executive Officer Andrew Rees reported open-market sales of Crocs common stock on June 5, 2026 through the REES FAMILY LIVING TRUST, where he serves as trustee with voting and investment power. The trust sold a total of 32,688 shares in three blocks at weighted average prices of $116.9702, $117.9443, and $119.1099 per share, across multiple trades within narrow price ranges. Following these transactions, Rees continues to hold 475,789 shares directly, alongside his indirect holdings through the trust.